Skip to main content
. 2017 Apr 21;2(5):988–994. doi: 10.1016/j.ekir.2017.04.004

Table 2.

Summary of laboratory results

Laboratory test Laboratory value at relapse of nephrotic syndrome Reference range Laboratory value at presentation for acute stroke Reference range
Leukocyte (109/l) 11.3 4.5–10.8 19 4.0–11.0
Hb (g/l) 138 117–157 117 120–160
Ht (%) 0.414 0.370–0.470 0.347 3.9–5.5
Platelet (104/mm3) 433 140–400 369 145–470
Creatinine (μmol/l) 57 53–97 56 42–89
Glucose (mmol/l) 4.1 4.0–6.2
HbA1c 0.0527 0.0440–0.0600
Albumin (g/l) 22 35–52 13 36–45
Protein/creatinine spot ratio (g/mmol) 1.397 0.828
Proteinuria (g/24 h) 4.84
Cholesterol (mmol/l) 9.33 8.25 3.40–7.30
HDL (mmol/l) 1.03 0.95 0.90–2.38
LDL (mmol/l) 7.2 5.68
Non–HDL cholesterol (mmol/l) 8.30 7.30
Triglycerides (mmol/l) 2.45 0.45–2.25 3.55 0.43–2.69
C reactive protein (mg/l) <5.0 <9.99
aPTT (s) 23 22–31
INR 1.0 0.9–1.2
Thrombin time (s) 23 14–18
Fg (g/l) 5.39 2.00–4.50
AT III (U/l) 1.24 0.80–1.20
Functional protein C (U/l) 1.45 0.70–1.40
Free protein S antigen (U/l) 1.23 0.69–1.31
Homocysteine (μg/l) 10 <12
C3 (g/l) 1.08 0.85–2.00
C4 (g/l) 0.23 0.10–0.50
ANA Negative Negative
ENA Negative
Anti-PR3 (AU) <0.2 0.0–0.9 <0.2 0.0–0.9
Antimyeloperoxidase (AU) 7.7 0.0–0.9 2.2 0.0–0.9
Anti–glomerular basal membrane <0.2 <1.0
Serum anti–PLAR2 antibody Weakly positive
Factor V Leiden Negative
Mutation factor II Negative
Lupus anticoagulant Negative
Anti–cardiolipins IgM (MPL-U/ml) 0.3 <12.5
Anti–cardiolipin IgG (GPL-U/ml) <1.6 <15

aPTT, activated partial thromboplastin time; ANA, antinuclear antibody; AT III, antithrombin III; AU, arbitrary units; ENA, extractable nuclear antigens; Fg, fibrinogen; GPL-U, G phospholipids-unit; Hb, hemoglobin; HDL, high-density lipoprotein; Ht, hematocrite; INR, international normalized ratio; LDL, low-density lipoprotein; MPL-U, M phospholipids-unit; MPO, myeloperoxidase; PLAR2, phospholipase A2 receptor.